Templeton DM - Search Results

1

Studies of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one in thalassemia patients.

Olivieri NF, Koren G, St Louis P, Freedman MH, McClelland RA, Templeton DM. Olivieri NF, et al. Among authors: templeton dm. Semin Hematol. 1990 Apr;27(2):101-4. Semin Hematol. 1990. PMID: 2190316 Clinical Trial. No abstract available.

2

Clinical studies on iron chelation in patients with thalassemia major.

Freedman MH, Olivieri N, Benson L, Liu P, McClelland R, St Louis P, Templeton D, Koren G. Freedman MH, et al. Haematologica. 1990 Sep-Oct;75 Suppl 5:74-83. Haematologica. 1990. PMID: 2086384 Review. No abstract available.

3

Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia.

Olivieri NF, Koren G, Matsui D, Liu PP, Blendis L, Cameron R, McClelland RA, Templeton DM. Olivieri NF, et al. Among authors: templeton dm. Blood. 1992 May 15;79(10):2741-8. Blood. 1992. PMID: 1586721 Free article.

4

Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients.

Olivieri NF, Koren G, Hermann C, Bentur Y, Chung D, Klein J, St Louis P, Freedman MH, McClelland RA, Templeton DM. Olivieri NF, et al. Among authors: templeton dm. Lancet. 1990 Nov 24;336(8726):1275-9. doi: 10.1016/0140-6736(90)92962-h. Lancet. 1990. PMID: 1978115 Clinical Trial.

5

Evaluation of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients.

Olivieri NF, Templeton DM, Koren G, Chung D, Hermann C, Freedman MH, McClelland RA. Olivieri NF, et al. Among authors: templeton dm. Ann N Y Acad Sci. 1990;612:369-77. doi: 10.1111/j.1749-6632.1990.tb24324.x. Ann N Y Acad Sci. 1990. PMID: 2291564 Clinical Trial. No abstract available.

6

Iron-chelation therapy with oral deferiprone in patients with thalassemia major.

Olivieri NF, Brittenham GM, Matsui D, Berkovitch M, Blendis LM, Cameron RG, McClelland RA, Liu PP, Templeton DM, Koren G. Olivieri NF, et al. Among authors: templeton dm. N Engl J Med. 1995 Apr 6;332(14):918-22. doi: 10.1056/NEJM199504063321404. N Engl J Med. 1995. PMID: 7877649 Free article. Clinical Trial.

7

Iron-balance and dose-response studies of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients with sickle cell disease.

Collins AF, Fassos FF, Stobie S, Lewis N, Shaw D, Fry M, Templeton DM, McClelland RA, Koren G, Olivieri NF. Collins AF, et al. Among authors: templeton dm. Blood. 1994 Apr 15;83(8):2329-33. Blood. 1994. PMID: 8161801 Free article.

8

Oral iron chelation with 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron loaded thalassemia patients.

Olivieri NF, Matsui D, Liu PP, Blendis L, Cameron R, McClelland RA, Templeton DM, Koren G. Olivieri NF, et al. Among authors: templeton dm. Bone Marrow Transplant. 1993;12 Suppl 1:9-11. Bone Marrow Transplant. 1993. PMID: 8374574 Clinical Trial.

9

Growth failure and bony changes induced by deferoxamine.

Olivieri NF, Koren G, Harris J, Khattak S, Freedman MH, Templeton DM, Bailey JD, Reilly BJ. Olivieri NF, et al. Among authors: templeton dm. Am J Pediatr Hematol Oncol. 1992 Spring;14(1):48-56. doi: 10.1097/00043426-199221000-00007. Am J Pediatr Hematol Oncol. 1992. PMID: 1550263

10

Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.

Parkes JG, Randell EW, Olivieri NF, Templeton DM. Parkes JG, et al. Among authors: templeton dm. Biochim Biophys Acta. 1995 Apr 13;1243(3):373-80. doi: 10.1016/0304-4165(94)00162-q. Biochim Biophys Acta. 1995. PMID: 7727512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters